Pulmonary Function Testing Systems Market Statistics Insights 2028

Pulmonary Function Testing Systems Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Cart-Based PFT Systems and Stationary PFT Systems), Test Type (Spirometry, Lung Volume, Gas Exchange Testing, Maximum Voluntary Ventilation, Oxygen Titration Test, and Others), Component (Hardware, Software, and Services), Application (Chronic Obstructive Pulmonary Disorder, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, and Others), and End User (Hospitals, Specialty Clinics, and Diagnostic Laboratories)

  • Report Code : TIPRE00017822
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 220

Pulmonary Function Testing Systems Market Statistics Insights 2028

Buy Now

The pulmonary function testing systems market size is expected to reach US$ 401.83 million by 2028 from US$ 274.10 million in 2022. The pulmonary function testing systems market is estimated to record a CAGR of 6.6% from 2022 to 2028.

Pulmonary functioning testing (PFT) is a set of noninvasive tests used to measure how well a patient’s lungs are working. These tests are important in diagnosing and treating those with respiratory diseases. In order to perform the tests and obtain accurate results, it is important to use the right types of PFT equipment and machines. The pulmonary functioning testing system is made up of several devices that are used to measure different aspects of lung function. This can include how well the lungs take in and expel air, how efficiently they transfer oxygen to the blood, and how much air they can hold. PFTs measure lung volumes, capacities, and the amount of gas exchange. The rising incidence of lung-related disorders and occupational lung diseases is contributing to the growing pulmonary function testing systems market size. However, the risk of cross-contamination and the lack of skilled professionals are hampering the market growth.

The pulmonary function testing systems market has been segmented based on type, test type, component, application, end user, and geography. In terms of geography, the market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as pulmonary function testing systems market trends, technological advancements, market dynamics, and the competitive landscape analysis of leading market players.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Pulmonary Function Testing Systems Market: Strategic Insights

Pulmonary Function Testing Systems Market
  • CAGR
    CAGR (2022 - 2028)
    6.6%
  • Market Size 2022
    US$ 274.10 Million
  • Market Size 2028
    US$ 401.83 Million

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • SCHILLER
  • COSMED srl
  • MGC Diagnostics Corporation
  • Ganshoran Medizin Electronic
  • ndd Medical Technologies
  • Morgan Scientific Inc
  • Pulm One Advanced Medical Devices Ltd
  • CHEST M I Inc
  • Vyaire Medical Inc

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market SegmentType
  • Cart-Based PFT Systems and Stationary PFT Systems
Market SegmentTest Type
  • Spirometry
  • Lung Volume
  • Gas Exchange Testing
  • Maximum Voluntary Ventilation
  • Oxygen Titration Test
Market SegmentComponent
  • Hardware
  • Software
  • Services
Market SegmentApplication
  • Chronic Obstructive Pulmonary Disorder
  • Asthma
  • Chronic Shortness of Breath
  • Restrictive Lung Disease
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Rising Incidence of Lung-Related Disorders

According to the British Lung Foundation 2023 report, ~10,000 people in the UK are newly diagnosed with lung disease every week. Additionally, lung diseases account for more than 70,00,000 hospital admissions, with 6 million inpatient bed-days in the UK annually. Therefore, pulmonary function testing (PFT) systems prove useful in diagnosing and monitoring. The PFT systems provide accurate results, particularly lung volume, capacity, rates of flow, and gas exchange. Additionally, PFT systems utilization assists in assessing treatment for asthma, emphysema, and other chronic lung problems. Through the assessment of lung volumes, capacities, rates of flow, and gas exchange, PFTs can provide information that can be evaluated by physicians to help diagnose certain lung disorders effectively and decide the right treatment for patients. Further, PFTs are noninvasive procedures and are usually recommended by physicians for patients with no hospital stay. Commercial pulmonary function testing systems available in the market include spirometry. Spirometry testing is useful for determining if the patient is suffering from lung disease, type of lung disease, progression of the lung disease, and impairment of lung disease. Spirometry measures airflow and can evaluate a broad range of lung diseases among patients. Thus, the rising incidence of lung-related disorders is fueling the use of pulmonary function testing systems.

Type-Based Insights

Based on type, the pulmonary function testing systems market is segmented into cart-based PFT systems and stationary PFT systems. The cart-based segment held a larger share of the market in 2022. Moreover, the cart-based segment is anticipated to register a higher CAGR in the market during the forecast period.

Test Type-Based Insights

In terms of test type, the pulmonary function testing systems market has been segmented into spirometry, lung volume, gas exchange testing, maximal voluntary ventilation, oxygen titration tests, and others. The spirometry segment held the largest share of the market in 2022. Moreover, the lung volume segment is anticipated to register the highest CAGR in the market during the forecast period.

Component-Based Insights

Based on component, the pulmonary function testing systems market has been segmented into hardware, software, and services. The hardware segment held the largest share of the market in 2022. The software segment is anticipated to register the highest CAGR in the market during the forecast period.

Application-Based Insights

Based on application, the pulmonary function testing systems market has been segmented into chronic obstructive pulmonary disease (COPD), asthma, chronic shortness of breath, restrictive lungs diseases, and others. The chronic obstructive pulmonary disease (COPD) segment held the largest share of the market in 2022. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the pulmonary function testing systems market has been segmented into hospitals, specialty clinics, and diagnostic centers. The hospitals segment held the largest share of the market in 2022. The specialty clinics segment is anticipated to register the highest CAGR in the market during the forecast period.

COVID-19 is a respiratory system infection that may rapidly cause pneumonia-like symptoms and chest infections. This may result in lowering the health conditions of the patient. The ventilators help manage the gas exchange of the patients. Due to the COVID-19 outbreak, there was a very high demand for pulmonary function testing systems. American Lung Association and Centers for Disease Control and Prevention recommended that patients with mild symptoms of COVID-19 carry out pulmonary function testing to check the lung capacity of the patient. Pulmonary function testing is an ideal tool for assessing the physiological impact of a virus that largely attacks the cardiopulmonary system. The technology measuring airflow, lung volumes, and the ability for oxygen and carbon dioxide to transfer between the alveoli and the bloodstream are well established, and facilities to perform these tests are found around the US.

Companies in the pulmonary function testing systems market commonly adopt product launches and expansion strategies to expand their footprint across the world and meet the growing demand. Their focus on product innovation allows them to cater to changing customer demands and maintain their brand name across the globe.

  • In June 2022, ndd Medical Technologies (ndd) updated the entire EasyOne product range, including the EasyOne Air, Easy on-PC, EasyOne Pro, and EasyOne Pro LAB, to be compliant with the ATS/ERS Standardization of Spirometry 2019.
  • In April 2021, Vyaire Medical announced the European launch of ArtiQ.PFT, an automated tool driven by artificial intelligence that instantly interprets pulmonary function tests (PFTs). ArtiQ.PFT is the first cloud-based PFT solution that leverages artificial intelligence.

In terms of geography, the global pulmonary function testing systems market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Pulmonary Function Testing Systems Market Report Scope

Report Attribute Details
Market size in 2022 US$ 274.10 Million
Market Size by 2028 US$ 401.83 Million
Global CAGR (2022 - 2028) 6.6%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Type
  • Cart-Based PFT Systems and Stationary PFT Systems
By Test Type
  • Spirometry
  • Lung Volume
  • Gas Exchange Testing
  • Maximum Voluntary Ventilation
  • Oxygen Titration Test
By Component
  • Hardware
  • Software
  • Services
By Application
  • Chronic Obstructive Pulmonary Disorder
  • Asthma
  • Chronic Shortness of Breath
  • Restrictive Lung Disease
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • SCHILLER
  • COSMED srl
  • MGC Diagnostics Corporation
  • Ganshoran Medizin Electronic
  • ndd Medical Technologies
  • Morgan Scientific Inc
  • Pulm One Advanced Medical Devices Ltd
  • CHEST M I Inc
  • Vyaire Medical Inc
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Company Profiles

  • COSMED Srl
  • MGC Diagnostics Corp
  • Morgan Scientific Inc
  • Minato Medical Science Co Ltd
  • Schiller AG
  • Chest MI Inc
  • Vyaire Medical Inc
  • ndd Medical Technologies Inc
  • PulmOne Advanced Medical Devices Ltd
  • KoKo PFT Ltd
Report Coverage

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Segment Covered

Type, Test Type, Component, Application, and End User

Regional Scope

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


Who are the key players in the pulmonary function testing systems market?

COSMED Srl, MGC Diagnostics Corp, Morgan Scientific Inc, Minato Medical Science Co Ltd, Schiller AG, Chest MI Inc, Vyaire Medical Inc, ndd Medical Technologies Inc, PulmOne Advanced Medical Devices Ltd, KoKo PFT Ltd, and among others are among the leading companies operating in the pulmonary function testing systems market.

What is the regional market scenario of the pulmonary function testing systems market?

Global pulmonary function testing systems market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.

Which end user segment held the largest market share in the pulmonary function testing systems market?

Hospitals segment dominated the global pulmonary function testing systems market and accounted for the largest market share during the forecast period of 2022-2028.

Which application segment held the largest market share in the pulmonary function testing systems market?

Based on the application, chronic obstructive pulmonary disorder segment took the forefront leaders in the worldwide market by accounting largest share in 2021.

Which type segment led the pulmonary function testing systems market?

Based on type segment, the cart-based PFT systems segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

What are the driving factors for the pulmonary function testing systems market across the globe?

Rising incidence of lung-related disorders and occupational lung diseases are the most significant factors responsible for the overall market growth.

What is meant by the pulmonary function testing systems market?

Pulmonary functioning testing (PFT) is a set of noninvasive tests that are used to measure how well a patient’s lungs are working. This is important in the diagnosis and treatment of those with respiratory diseases. In order to perform the tests and obtain accurate results, it is important to use the right types of PFT equipment and machines. There are several different devices in system. Pulmonary functioning testing system is made up of several devices that are used to measure different aspects of lung function. This can include how well the lungs take in and expel air, how efficiently they transfer oxygen to the blood, and how much air the lungs can hold. PFT’s measure lung volumes, capacities, and the amount of gas exchange.

The List of Companies - Pulmonary Function Testing Systems Market

  1. SCHILLER
  2. COSMED srl
  3. MGC Diagnostics Corporation
  4. Ganshoran Medizin Electronic
  5. ndd Medical Technologies
  6. Morgan Scientific Inc.
  7. Pulm One Advanced Medical Devices Ltd
  8. CHEST M.I., Inc
  9. Vyaire Medical, Inc.
  10. Koko LLC

Trends and growth analysis reports related to Medical Device : READ MORE..